Skip to main content
Elsevier
View Cart
openUserAccount

Books in Hepatology

BooksJournals
41-50 of 70 results in All results

Alcoholic Liver Disease, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 20-3
  • July 8, 2016
  • Stanley Cohen
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 4 5 9 7 3 - 0
  • eBook
    9 7 8 - 0 - 3 2 3 - 4 5 9 7 4 - 7
Alcohol abuse remains a significant problem world-wide. The most commonly affected organ remains the liver with a risk of alcoholic liver disease (ALD) which can range from asymptomatic to alcoholic hepatitis to alcoholic cirrhosis. In 2010, alcohol-attributable cirrhosis was responsible for 0.9% of all global deaths. Given the sheer magnitude of alcohol abuse and alcoholic liver disease, an update on this topic is pertinent and relevant. This issue will focus on a variety of topics including alcoholism, the pathogenesis of ALD, the spectrum of ALD, the pathology of ALD, and the long-term management of patients with ALD. Alcoholic hepatitis is a particular type of ALD with a high mortality. This issue will explore the syndrome of alcoholic hepatitis, its prognostic markers, and the available therapies. Because alcohol intake can influence so many other conditions of the liver (especially hepatitis C), articles in this issue will also explore the impact of alcohol abuse on other liver conditions. In addition, several other topics such as nutritional therapy for ALD, ALD and liver cancer, and ALD and infection risk will be explored. Also, even though it is quite controversial, we will also explore liver transplant as a therapy for alcoholic liver disease including alcoholic hepatitis.

Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 20-2
  • April 15, 2016
  • Paul J. Gaglio
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 4 1 6 9 6 - 2
  • eBook
    9 7 8 - 0 - 3 2 3 - 4 1 6 9 7 - 9
Due to the current obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is prevalent in a significant portion of the United States patient population. It is being increasingly recognized that NAFLD affects both adults and children and can progress to end stage liver disease with resultant cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, several extrahepatic conditions may be linked to NAFLD including cardiovascular disease, insulin requiring and type 2 diabetes mellitus, obstructive sleep apnea, colonic adenomas, hyperuricemia, vitamin D deficiency, hyperferritinemia, pancreatic steatosis, hypothyroidism, and polycystic ovarian syndrome. Therapies for NAFLD are evolving rapidly. This issue will analyze patient demographics, risk factors, pathophysiology, patient presentation, and treatments for NAFLD.

Current Management of Hepatitis C Virus, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 19-4
  • January 4, 2016
  • Fred Poordad
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 4 1 3 3 6 - 7
  • eBook
    9 7 8 - 0 - 3 2 3 - 4 1 3 3 7 - 4
Clinical information about Hepatitis C is quickly outdated, so Dr. Poordad has assembled expert authors to provide state-of-the-art clinjcal reviews for hepatologists. This issue is uniquely organized to present articles based on therapeutic regimens for certain types of patients: Regimens for the Treatment-Naïve Patient; Regimens for Treatment of the Interferon-Failure Patient; Regimens for DAA Failure Patients; Regimens for the Cirrhotic Patient; Regimens for the Peri-Transplant Patient; Regimens for the HIV-Co-Infected Patient; and Next-generation Regimens: The Future of HCV Therapy. This presentation will be very clinically relevant for the practicing hepatologist.

Advances in Cholestatic Liver Diseases, An issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 20-1
  • December 7, 2015
  • Cynthia Levy
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 4 2 9 9 1 - 7
  • eBook
    9 7 8 - 0 - 3 2 3 - 4 2 9 9 2 - 4
Dr. Levy has secured the field’s top experts to offer the latest clinical reviews on cholestatic liver disease. The issue will include articles devoted to The Gut-Liver Axis; Update on Genetics in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis; New thoughts on IgG4 Associated Cholangitis; Cancer Risk and Surveillance in PSC; Novel Therapies for PBC; and Liver transplantation for Cholestatic Liver Diseases, to name a few. Dr. Levy’s issue will be the most current authority on cholestatic liver disease.

New Advances in Hepatic Encephalopathy, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 19-3
  • July 27, 2015
  • Robert S. Brown Jr
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 3 7 6 0 3 - 7
  • eBook
    9 7 8 - 0 - 3 2 3 - 3 7 6 0 4 - 4
Dr. Brown provides a timely upate on the clinical diagnosis and management of Hepatic Encephalopathy. His issue addresses current hot topics including Role of NH4 in Pathogenesis of Hepatic Encephalopathy; How to diagnose and manage HE in fulminant hepatic failure; New methods of Brain Imaging and testing (eg PET) and Hepatic Encephalopathy; Management New agents for HE (focus on NH4 lowering drugs used in UCD); Legal responsibility of MD when he diagnoses HE; Diets in Encephalopathy; and Neurological manifestations of HE.

Hepatocellular Carcinoma in Adults and Children, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 19-2
  • May 7, 2015
  • Adrian Reuben
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 3 9 3 4 0 - 9
  • eBook
    9 7 8 - 0 - 3 2 3 - 3 9 3 4 1 - 6
Dr. Reuben provides a timely update to the topic of HCC, which was last covered in 2011. The highly respected authors in his issue address advances in imaging for diagnosis, surgical resection and liver transplantation, and local and systemic therapy. The breadth of the topic is covered, with articles devoted to histopathology, classification and staging, and screening and detection.

Consultations in Liver Disease, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 19-1
  • December 2, 2014
  • Steven L. Flamm
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 3 5 4 4 3 - 1
  • eBook
    9 7 8 - 0 - 3 2 3 - 3 5 4 6 1 - 5
Dr. Flamm has invited a group of distinguished hepatologists to provide insight into the assessment of a variety of scenarios where clinical judgment based on experience and published literature is an invaluable addition to the care of individual patients. Articles included in the issue address the following topics: Evaluation and Management of Portal Vein Thrombosis, Liver Disease in the HIV patient, Hepatocellular Carcinoma, Evaluation of Renal Insufficiency in the Cirrhotic Patient, Contemporary Management of Autoimmune Hepatitis, Diagnosis and Treatment of Overlap Syndromes, Ins and Outs of Liver Imaging for the Gastroenterologist, Contemporary Assessment of Hepatic Fibrosis, A Primer on Liver Transplantation Immunosuppressive Agents for the Gastroenterologist, Evaluation of Jaundice in the Hospitalized Patient, Liver Disease in the Adolescent, Evaluation and Management of Hemochromatosis and How and When to Administer Hepatitis A and B Virus Vaccinations. These are all common contemporary reasons for consultations for Gastroenterologists and Hepatologists and this issue will address the issues in a pragmatic way.

GI/Liver Secrets Plus

  • 5th Edition
  • November 13, 2014
  • Peter R. McNally
  • English
  • eBook
    9 7 8 - 0 - 3 2 3 - 3 1 5 7 7 - 7
Stay up to date on today's most common GI and liver disorders and their management with GI/Liver Secrets Plus. This enhanced medical reference book is an excellent resource for understanding the physiology and therapy in hepatic and digestive disease. Whether preparing for an exam or quickly checking a clinical question, the user-friendly Secrets Series® style makes this book a valuable addition to your library!

Interventional Procedures in Hepatobiliary Diseases, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 18-4
  • October 22, 2014
  • Andres Cardenas
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 3 2 6 5 8 - 2
  • eBook
    9 7 8 - 0 - 3 2 3 - 3 2 6 5 9 - 9
The field of hepatobiliary diseases has advanced enormously in the past 3 decades. The incorporation of new diagnostic and therapeutic interventions in clinical hepatology as well as liver transplantation has exponentially grown and specialty fields have emerged within the liver disease arena. Interventional procedures play a critical role in the management of patients with hepatobiliary diseases as they offer diagnostic and definite treatment options for an array of conditions. Interventions include those that directly measure portal pressure, perform transjugular liver biopsy and place transjugular intrahepatic portsosystemic shunts as therapy for complications of portal hypertension. Other commonly performed intervention is digestive and hepatobiliary endoscopy which offers not only diagnostic but also therapeutic choices in various areas such as portal hypertension and hepatobiliary disease. Endoscopy plays a fundamental role in the management of patients with almost all types of liver disease. Additionally, both the fields of hepatology and endoscopy have become very specialized and thus a thorough knowledge of the indications, findings, therapeutic possibilities and complications that arise from endoscopic interventions is a must for the practicing clinician. The rising incidence of liver cancer has also placed radiofrequency ablation and chemoembolization of liver lesions at the forefront of interventional therapies for hepatocellular carcinoma. Finally the management of acute liver failure has certainly evolved with new therapeutic options such as liver assist devices that can help manage these patients in the intensive care unit. This issue of Clinics in Liver Disease devoted to Interventional Hepatology is a timely and unique one. The Guest Editors have assembled an outstanding group of experts in several fields that can provide practitioners with state of the art and evidence based articles that help manage patients with hepatobiliary disease.

Liver Transplantation: Update of Concepts and Practice, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 18-3
  • August 28, 2014
  • Kalyan Ram Bhamidimarri
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 3 2 0 1 6 - 0
  • eBook
    9 7 8 - 0 - 3 2 3 - 3 2 0 3 5 - 1
A number of areas within liver transplant continue to evolve as the field matures. The advent of increasingly effective therapy for HCV will dramatically reduce the burden of recurrent disease within the next few years. HCC has become a well established indication for transplant with an increasing emphasis on adjuvant therapies to reduce the risk of tumor recurrence and potentially expand the acceptable limits of tumor burden amenable to liver transplant. Renal dysfunction is a frequent complication of decompensated liver disease and an important predictor of diminished post-transplant survival. Newer approached to therapy including terlipressin will reduce the impact of renal dysfunction in liver transplant candidates and potentially reduce the need for combined liver/kidney transplant. Increasing attention is being paid to role of comorbidities such as diabetes and hypertension on long-term recipient outcomes. Retransplantation remains a challenge with a variety of models available to predict outcomes. Cardiac disease pretransplant is an area of active investigation with newer entities such as cirrhotic cardiomyopathy a growing concern. These are some of many evolving issues in liver transplant which will be addressed to update our readers and which in turn will enhance the care of patients with liver disease.